Certis Therapeutics, a spin-off of IHU Liryc, raises €1.5 million to commercialize its first medical devices.


The specialist in mini-invasive MRI guided therapies, created two years ago, has just concluded its fundraising with Medevice lead (Medevice Capital III), as well as regional funds Aquiti Gestion (NACO), GSO Innovation and Crédit Agricole Aquitaine Expansion. The funds raised will be used to finance the next milestone in the development of Certis Therapeutics.

UN MATIN, LE COEUR DE JULIETTE, 14 ANS, S’EST ARRÊTÉ…

Juliette a été victime d’une mort subite cardiaque provoquée par un dysfonctionnement de son coeur. Grâce aux découvertes et aux innovations scientifiques de l’Institut Liryc, elle a pu être sauvée. Ne laissons pas les maladies du rythme cardiaque emporter des vies.

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.